MedPath

Development of a novel method to prevent cognitive decline using a "healing smart space" that stimulates the five senses

Not Applicable
Recruiting
Conditions
Mild cognitive impairment, behavior and psychological symptoms of dementia, stress
Registration Number
JPRN-UMIN000046310
Lead Sponsor
Osaka Center for Cancer and Cardiovascular Disease Prevention
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.Under 20 years old. 2.MMSE-J score of 15 or less. 3.Have a visual impairment that prevents recognition of images even when vision is corrected with glasses, etc. 4.Have hearing impairment to the extent that they cannot hear sounds even with the use of hearing aids. 5.Self-reported susceptibility to motion sickness or VIMS. 6.Has difficulty in sitting up. 7.Cognitive function has declined to the extent that the patient is unable to answer the questionnaire (e.g., communication is not possible even with support when answering). 8.Has started donepezil, rivastigmine, galantamine, or memantine within the last 3 months. 9.Is judged by the principal investigator to be inappropriate for participation in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the Japanese version of the Montreal Cognitive Assessment (MoCA-J) between baseline and post-intervention
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath